Francesca L Facco1, David W Ouyang2, Phyllis C Zee3, Anna E Strohl4, Anna B Gonzalez2, Courtney Lim4, William A Grobman4. 1. Department of Obstetrics and Gynecology, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, PA. Electronic address: faccof@upmc.edu. 2. Department of Obstetrics and Gynecology, North Shore University Health System, Pritzker School of Medicine, University of Chicago, Evanston, IL. 3. Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL. 4. Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Abstract
OBJECTIVE: The objective of the study was to examine the relationship between sleep-disordered breathing (SDB) and adverse pregnancy outcomes in a high-risk cohort. STUDY DESIGN: This was a planned analysis of a prospective cohort designed to estimate the prevalence and trends of SDB in high-risk pregnant women. We recruited women with a body mass index of 30 kg/m(2) or greater, chronic hypertension, pregestational diabetes, prior preeclampsia, and/or a twin gestation. Objective assessment of SDB was completed between 6 and 20 weeks and again in the third trimester. SDB was defined as an apnea hypopnea index of 5 or greater and further grouped into severity categories: mild SDB (5-14.9), moderate SDB (15-29.9), and severe SDB (≥30). Pregnancy outcomes (preeclampsia, gestational diabetes, preterm birth, infant weight) were abstracted by physicians blinded to the SDB results. RESULTS: Of the 188 women with a valid early pregnancy sleep study, 182 had complete delivery records. There was no relationship demonstrated between SDB exposure in early or late pregnancy and preeclampsia, preterm birth less than 34 weeks, and small-for-gestational-age (<5%), or large-for-gestational-age (>95%) neonates. Conversely, SDB severity in early pregnancy was associated with the risk of developing gestational diabetes (no SDB, 25%; mild SDB, 43%; moderate/severe SDB, 63%; P = .03). The adjusted odds ratio for developing gestational diabetes for moderate/severe SDB was 3.6 (0.6, 21.8). CONCLUSION: This study suggests a dose-dependent relationship between SDB in early pregnancy and the subsequent development of gestational diabetes. In contrast, no relationships between SDB during pregnancy and preeclampsia, preterm birth, and extremes of birthweight were demonstrated.
OBJECTIVE: The objective of the study was to examine the relationship between sleep-disordered breathing (SDB) and adverse pregnancy outcomes in a high-risk cohort. STUDY DESIGN: This was a planned analysis of a prospective cohort designed to estimate the prevalence and trends of SDB in high-risk pregnant women. We recruited women with a body mass index of 30 kg/m(2) or greater, chronic hypertension, pregestational diabetes, prior preeclampsia, and/or a twin gestation. Objective assessment of SDB was completed between 6 and 20 weeks and again in the third trimester. SDB was defined as an apnea hypopnea index of 5 or greater and further grouped into severity categories: mild SDB (5-14.9), moderate SDB (15-29.9), and severe SDB (≥30). Pregnancy outcomes (preeclampsia, gestational diabetes, preterm birth, infant weight) were abstracted by physicians blinded to the SDB results. RESULTS: Of the 188 women with a valid early pregnancy sleep study, 182 had complete delivery records. There was no relationship demonstrated between SDB exposure in early or late pregnancy and preeclampsia, preterm birth less than 34 weeks, and small-for-gestational-age (<5%), or large-for-gestational-age (>95%) neonates. Conversely, SDB severity in early pregnancy was associated with the risk of developing gestational diabetes (no SDB, 25%; mild SDB, 43%; moderate/severe SDB, 63%; P = .03). The adjusted odds ratio for developing gestational diabetes for moderate/severe SDB was 3.6 (0.6, 21.8). CONCLUSION: This study suggests a dose-dependent relationship between SDB in early pregnancy and the subsequent development of gestational diabetes. In contrast, no relationships between SDB during pregnancy and preeclampsia, preterm birth, and extremes of birthweight were demonstrated.
Authors: Louise M O'Brien; Alexandra S Bullough; Anita V Shelgikar; Mark C Chames; Roseanne Armitage; Ronald D Chervin Journal: J Clin Sleep Med Date: 2012-06-15 Impact factor: 4.062
Authors: Joaquín Durán-Cantolla; Felipe Aizpuru; Jose María Montserrat; Eugeni Ballester; Joaquín Terán-Santos; Jose Ignacio Aguirregomoscorta; Mónica Gonzalez; Patricia Lloberes; Juan Fernando Masa; Mónica De La Peña; Santiago Carrizo; Mercedes Mayos; Ferrán Barbé Journal: BMJ Date: 2010-11-24
Authors: Francesca L Facco; William A Grobman; Jamie Kramer; Kim H Ho; Phyllis C Zee Journal: Am J Obstet Gynecol Date: 2010-05-26 Impact factor: 8.661
Authors: Stephen D Pittman; Najib T Ayas; Mary M MacDonald; Atul Malhotra; Robert B Fogel; David P White Journal: Sleep Date: 2004-08-01 Impact factor: 5.849
Authors: Sirimon Reutrakul; Nausheen Zaidi; Kristen Wroblewski; Helen H Kay; Mahmoud Ismail; David A Ehrmann; Eve Van Cauter Journal: J Clin Endocrinol Metab Date: 2013-08-21 Impact factor: 5.958
Authors: Nathaniel S Marshall; Keith K H Wong; Craig L Phillips; Peter Y Liu; Matthew W Knuiman; Ronald R Grunstein Journal: J Clin Sleep Med Date: 2009-02-15 Impact factor: 4.062
Authors: Sarah S Farabi; Linda A Barbour; Kristy Heiss; Nicole M Hirsch; Emily Dunn; Teri L Hernandez Journal: J Clin Endocrinol Metab Date: 2019-07-01 Impact factor: 5.958
Authors: Marquis Hawkins; Corette B Parker; Susan Redline; Jacob C Larkin; Phyllis P Zee; William A Grobman; Robert M Silver; Judette M Louis; Grace W Pien; Robert C Basner; Judith H Chung; David M Haas; Chia-Ling Nhan-Chang; Hyagriv N Simhan; Nathan R Blue; Samuel Parry; Uma Reddy; Francesca Facco Journal: Sleep Med Date: 2021-02-27 Impact factor: 3.492
Authors: Sandhya Kajeepeta; Sixto E Sanchez; Bizu Gelaye; Chunfang Qiu; Yasmin V Barrios; Daniel A Enquobahrie; Michelle A Williams Journal: BMC Pregnancy Childbirth Date: 2014-09-27 Impact factor: 3.007